Navigation Links
Traditional neurologic exams inadequate for predicting survival of cardiac arrest patients
Date:6/23/2010

PITTSBURGH, June 23 Traditional methods for assessing patients after cardiac arrest may be underestimating their chances for survival and good outcomes, according to a new study by University of Pittsburgh School of Medicine researchers now available online in the journal Resuscitation.

"The care of cardiac arrest patients has improved dramatically in recent years," noted lead author Jon C. Rittenberger, M.D., M.S., assistant professor of emergency medicine at Pitt. "Unfortunately, the neurological exams that are used to provide a prognosis for these patients appear inadequate, and it's time to re-examine their predictive value."

Cardiac arrest results in about 350,000 deaths each year. Currently, physicians assess pupil response, corneal reflexes and motor response to determine a patient's prognosis after resuscitation to restart the heart.

For this study, researchers retrospectively reviewed the neurologic examination findings for 272 cardiac arrest patients upon arrival at the hospital, 24 hours later and 72 hours later. Most of the subjects were men, and the mean age was 61. Most were treated with therapeutic hypothermia, which cools the body of a comatose patient to prevent brain injury and other organ damage.

The researchers found that 33 percent of the patients in the study survived, and 20 percent experienced a good outcome, defined as discharge to home or to an acute rehabilitation facility. The association between good outcomes and exam findings did not differ between those treated with or without therapeutic hypothermia. Surprisingly, even those with poor motor examination scores on neurologic exams after 24 and 72 hours showed survival rates that were higher than what clinicians traditionally would have predicted.

The researchers looked specifically at the Glasgow Coma Score (GCS) motor response, both at 24 and 72 hours after cardiac arrest. Existing guidelines suggest that a GCS motor response of 3 or less is highly predictive of mortality. Rittenberger and his team found that survival was 17 percent at 24 hours and 20 percent at 72 hours for those with a GCS of 3 or less. When the investigators used a more conservative GCS motor response of 2 or less, the survival rate was 14 percent at 24 hours and 18 percent at 72 hours.

Consistent with existing guidelines, the researchers found that a lack of pupil or corneal response at 72 hours appeared to exclude survival or good outcome.

"The good news is that advances in care for cardiac arrest patients appear to be improving survival rates and positive outcomes," said Dr. Rittenberger. "In light of these changes, we need to re-evaluate and expand our tools for providing a prognosis to patients and their families."

Dr. Rittenberger is supported by a grant from the National Center for Research Resources, part of the National Institutes of Health, as well as an unrestricted grant from the National Association of EMS Physicians/Zoll EMS Resuscitation Research Fellowship.


'/>"/>

Contact: Wendy Zellner
ZellnerWL@upmc.edu
412-586-9777
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels
2. Traditional Yoga meets Non-traditional Dog Yoga
3. Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent
4. Robby Wash High Efficiency Laundry Detergent Offers 25% off Coupon – Replaces 75 lbs. of Traditional Laundry Detergent Saving $100 Annually
5. HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions
6. Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding
7. Ablation proved as effective as traditional surgery in treating kidney cancer
8. My1Stop.com Launches Plastic Table Talkers -- Innovative Table Top Signs That Ship Flat and Outlast Traditional Acrylic Holders
9. Bypass procedure used during infant heart surgery does not impair later neurological outcomes
10. Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children
11. Brain Science Institute announces license agreement to develop treatments for neurological disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: